The gut microbiome is a community of microbial organisms that live in our gastrointestinal tract and coexist with us in a mutually beneficial relationship. These microorganisms play a pivotal role in our overall health, especially in shaping our immune system. This means that good gut health can help boost your immunity.

But how can we investigate this intricate relationship? Many molecules produced by the gut microbiome can be measured in exhaled breath and can inform us about the interactions between our microbiome and immune system.

The Impacts of our Microbiome on our Immune System, Health and Disease

Our gut is constantly exposed to the environment including through what we eat and drink. The “good” microbes in our gut microbiome are in frequent competition with potentially “bad” microorganisms as they both compete for space and nutrients in our gut. As such, our microbiomes have evolved to fend off pathogens and disease-causing microbes and “educate” the immune system so that we maintain a healthy balanced gut. This has created a mutual relationship between our immune system and microbiome, controlled by a variety of complex chemical signals and interactions. This relationship is complicated by the effect of our diet which may alter these interactions¹.

Some key molecules that regulate our immunity are short-chain fatty acids (SCFAs). These are produced through the fermentation of fiber by our “good” bacteria, in the intestines. Many of these SCFAs can be measured in breath and they can improve the activity of our immune cells, improve the protection of the gut barrier, and reduce inflammation. In fact, SCFAs can also contribute to the suppression of autoimmune diseases².

Dysbiosis (where our microbiome is out of balance) can reduce SCFA production, which in turn adversely affects immune function. An altered microbiome may also produce harmful and inflammatory molecules that can increase the permeability of the intestinal barrier. These molecules have been linked to inflammatory bowel disease (IBD) and autoimmune diseases^{1, 2}.

Gut dysbiosis has been recorded in type 1 diabetes patients. SCFAs usually shield the pancreas from damage caused by inflammatory molecules. However, people deficient in SCFAs are at a higher risk of an autoimmune response. Notably, abnormal SCFA levels and irregular microbiome diversity have been reported in various autoimmune diseases including rheumatoid arthritis, lupus, and multiple sclerosis, amongst others, reflecting the microbiome’s influence extending beyond solely gut health².

Implications for Treatment and Research

A greater understanding of the interactions between the microbiome and the immune system is rapidly transforming how we approach chronic inflammatory conditions and diagnostics. For instance, short-chain fatty acids (SCFAs) produced by beneficial microbes have profound regulatory effects on immune health. Consequently, targeted protocols that support these specific microbial pathways hold immense therapeutic potential.

However, because the human microbiome is entirely unique to the individual, generic immune-boosting regimens or blind dietary shifts can be ineffective or even counterproductive. What balances the immune response in one person might trigger dysbiosis or inflammation in another. This high level of individual variation is why successful clinical outcomes rely on precise, personalized data rather than generalized advice.

Breath analysis provides a non-invasive, highly sensitive method for mapping real-time metabolic activity within the gut. Because it tracks immediate fluctuations in response to diet, lifestyle, or therapeutic interventions, it is uniquely suited for the longitudinal monitoring required to balance immune-driven gut health.

How OMED Health Is Bridging the Gap

At OMED Health, we are dedicated to advancing this science—deeply researching how the microbiome responds to various nutritional stimuli and identifying specific breath biomarkers to develop next-generation clinical tests.

That is why our medical-grade Breath Analyzer is exclusively integrated into our clinician-led SIBO and IMO breath testing kits. Distributed and managed entirely by independent healthcare professionals, this system allows you to collect precise hydrogen and methane data from home, which syncs directly to your practitioner’s specialist dashboard via the OMED Health App. By evaluating these gas curves alongside your systemic symptoms, your practitioner can pinpoint underlying overgrowths that may be dysregulating your immune pathways, allowing them to build a highly tailored, data-driven recovery plan.

Your Built-In Clinical Safety Net

Chronic immune system activation and gut dysbiosis can form a stubborn, self-reinforcing cycle, complex overgrowths that often require targeted medical clearance to fully resolve. To ensure complete continuity of care, our platform features an integrated medical safety net. If your testing data reveals a deep-seated microbial imbalance that resists standard nutritional adjustments or herbal protocols designed by your practitioner, they can seamlessly escalate your care through our ecosystem. This grants you direct access to an OMED Health medical doctor for expert clinical review and targeted antibiotic prescriptions—ensuring your immune and digestive health are fully supported by an end-to-end clinical pathway.

References:

1. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014 Mar 27;157(1):121-41. doi: 1016/j.cell.2014.03.011.
2. Kim CH. Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cell Mol Immunol. 2023 Apr;20(4):341-350. doi: 1038/s41423-023-00987-1.
3. Neyrinck AM, Rodriguez J, Zhang Z, Nazare JA, Bindels LB, Cani PD, Maquet V, Laville M, Bischoff SC, Walter J, Delzenne NM. Breath volatile metabolome reveals the impact of dietary fibres on the gut microbiota: Proof of concept in healthy volunteers. EBioMedicine. 2022 Jun;80:104051. doi: 1016/j.ebiom.2022.104051